GlassScriptPhysician profile
Luke Oakley
NPI 1548571656
$316,661.87
in general payments reported to CMS, 2019-2025
24 companies · $29K in 2025
The $29K reported for 2025 was more than what 95% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $3,558 · 2021: $52K · 2022: $75K · 2023: $57K · 2024: $89K · 2025: $29K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $133K · Travel and Lodging: $31K · Food and Beverage: $5,319 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $133,025.00 |
| Travel and Lodging | $31,488.00 |
| Food and Beverage | $5,319.10 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $303,061.30 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia, Pascal |
| Abbott Laboratories | $3,203.71 | 2019-2025 | Amplatzer, Dragonfly Opstar, Xience Skypoint |
| Medtronic Vascular, INC. | $2,134.62 | 2019-2020 | |
| Boston Scientific Corporation | $1,968.43 | 2019-2025 | Watchman Access System, Wolverine Coronary Cutting Balloon, Watchman Flx |
| Baylis Medical Company INC | $1,298.61 | 2019 | |
| Abiomed | $1,207.09 | 2019-2025 | Impella |
| W. L. Gore & Associates, INC. | $792.23 | 2019 | |
| Inari Medical, INC. | $563.58 | 2022-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Medtronic, INC. | $557.82 | 2021-2025 | Corevalve Evolut R, Aurora Ev-Icd Mri Surescan |
| Penumbra, INC. | $380.02 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $339.94 | 2022-2024 | Lifevest |
| Shockwave Medical, INC | $318.88 | 2021-2025 | |
| Philips North America LLC | $205.47 | 2019-2025 | Igt Devices Undivided |
| Acist Medical Systems, INC. | $143.77 | 2019-2023 | |
| Cordis US Corp. | $99.09 | 2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $91.84 | 2022 | |
| Stryker Corporation | $59.72 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Cardiva Medical, INC. | $41.58 | 2023-2024 | Cardiva Vascade Mvp Vvcs 6-12f, Esophageal Cooling Device |
| Terumo Medical Corporation | $38.34 | 2023 | Optitorque, Glidewire |
| Biosense Webster, INC. | $37.35 | 2019 | |
| Cathworks, INC. | $36.94 | 2019 | |
| Amgen INC. | $34.59 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $28.96 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $17.99 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luke Oakley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.